Redpoint Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Redpoint Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,116	Closed	-$376K	–	662
2021 Q2	$376K	Sell	2,116 -206	-9%	-$35.7K	0.03%	530
2021 Q1	$382K	Hold	2,322	–	–	0.03%	511
2020 Q4	$383K	Hold	2,322	–	–	0.04%	426
2020 Q3	$331K	Sell	2,322 -4,642	-67%	-$575K	0.04%	451
2020 Q2	$768K	Sell	6,964 -589	-8%	-$65.1K	0.04%	390
2020 Q1	$753K	Sell	7,553 -353	-4%	-$45.6K	0.05%	366
2019 Q4	$1.18M	Hold	7,906	–	–	0.06%	358
2019 Q3	$1.01M	Hold	7,906	–	–	0.05%	372
2019 Q2	$1.13M	Hold	7,906	–	–	0.06%	359
2019 Q1	$1.13M	Hold	7,906	–	–	0.06%	367
2018 Q4	$980K	Hold	7,906	–	–	0.06%	358
2018 Q3	$1.33M	Hold	7,906	–	–	0.07%	331
2018 Q2	$1.36M	Hold	7,906	–	–	0.07%	328
2018 Q1	$1.19M	Buy	7,906 +1,106	+16%	+$162K	0.07%	338
2017 Q4	$915K	Buy	+6,800	New	+$943K	0.05%	361

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Redpoint Investment Management's JAZZ Position: Q3 2021 in Review

Redpoint Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 2,116 shares — an estimated $376K sold.

Redpoint Investment Management first reported a position in JAZZ in Q4 2017 and held it in 15 quarters. The position peaked at $1.36M in Q2 2018. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

Redpoint Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Redpoint Investment Management sold 2,116 Jazz Pharmaceuticals shares in Q3 2021, an estimated $376K.
Redpoint Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2017 and held it in 15 quarters.
Redpoint Investment Management's Jazz Pharmaceuticals position peaked at $1.36M in Q2 2018.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Redpoint Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.